OUR NEW PROFILE IS: (NASDAQ: KSPN)
OUR NEW PROFILE IS: (NASDAQ: KSPN) 150 Employees, Serving 5,000 Brands in 20 Countries The Entire Float is Under 4Million According to Yahoo Finance Yahoo Also Has Revenues Over $130 Million for 2022 ______________ Hello Everyone, We have another low float profile for todays session. Pull up KSPN Immediately and start your research. […]
BSGM Nasdaq Profile On Watch!
_______ OUR NEW PROFILE IS: (NASDAQ: BSGM) BIOSIG SEES POSITIVE MOMENTUM FROM SALES PIPELINE GROWTH OVER 3,000 PROCEDURES HAVE BEEN PERFORMED USING THE PURE EP™ SYSTEM WITH MORE THAN 80 PHYSICIANS AT 21 HOSPITALS ACROSS THE UNITED STATES SUBSTANTIAL AND GROWING IP PATENT PORTFOLIO IN 2022 THE CEO PURCHASED OVER 200K SHARES THE LAST TIME […]
NEW PROFILE (Nasdaq: LSDI)
OUR NEW PROFILE IS: (NASDAQ: LSDI) LUCY SCIENTIFIC DISCOVERY ANNOUNCES FIRST COMMERCIAL SALE OF PSILOCYBIN FOLLOWING INITIAL DELIVERY OF DMT AND 5-MEO-DMT TO HADASSAH BRAINLABS LUCY SCIENTIFIC TEAMS UP WITH PRAMANTHA GROUP TO SECURE KEY GOVERNMENT CONTRACTS AND GRANTS TO ENHANCE ITS MANUFACTURING CAPABILITIES IN EARLY FEBRUARY THE COMPANY CLOSED A $7.5MILL IPO *****HUGE BREAKING […]
(Nasdaq: MYNZ) Profile
OUR NEW PROFILE IS: (NASDAQ: MYNZ) __________ MAINZ BIOMED (NASDAQ: MYNZ) AIMS TO BECOME A LEADER IN THE MULTI-BILLION-DOLLAR COLORECTAL CANCER DIAGNOSTICS MARKET CE-IVD CLEARED FLAGSHIP PRODUCT COLOALERT IS THE FIRST DNA-BASED SCREENING TEST FOR COLORECTAL CANCER IN EUROPE MYNZ IS ALSO DEVELOPING PROPRIETARY GENETIC TESTING METHODS FOR PANCREATIC CANCER IN ADDITION TO COLOALERT, ALREADY […]
BRAND NEW PROFILE: (NASDAQ: IKT)
OUR NEW PROFILE IS: (NASDAQ: IKT) ______ VIEW THE INVESTOR PRESENTATION HERE Hello Everyone, We have another profile that is trading under a buck right now that sits on the Nasdaq that we want you to research. You know we loves these ones that are sitting under a dollar because of the massive swing potential. […]
(Nasdaq: CMND) Profile
OUR NEW PROFILE IS: (NASDAQ: CMND) __________ CMND TRADES IN CANADA (CSE: CMND) AS WELL AS GERMANY (FWB: CWY) READ THE INVESTOR PRESENTATION HERE _______________________ Hello Everyone, We have another exciting profile for you for for today’s session. This one operates in a unique, niche sector with a bright future ahead of it. With […]
Nasdaq: NMTC Profile
OUR NEW PROFILE IS: (NASDAQ: NMTC) Strategic partnership with Zimmer Biomet (NYSE:ZBH, ~$27B mkt cap) to exclusively commercialize and distribute EVO® diagnostic electrodes; accelerated payment of $3.5 million received in August 2022 Neurone® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use ****Breaking News This Morning***** NeuroOne® Awarded […]
BCAN Nasdaq Profile
OUR NEW PROFILE IS: (NASDAQ: BCAN) YAHOO FINANCE HAS THE ENTIRE FLOAT UNDER 1.2MILL!! THE EZ-G DEVICE REPRESENTED A $28 MILLION TRANSACTION BCAN IS AN EARLY PLAYER IN THE AI-POWERED ADULT TOY MARKET INSIDERS OWN OVER 64% OF THIS ONE!! _____________________ Pull up BCAN immediately. In the adult toy industry, AI and wearable sex toys have […]
NASDAQ: PBTS IS OUR NEW PROFILE!
OUR NEW PROFILE IS: (NASDAQ: PBTS) _________________ PBTS HAS OVER 300 EMPLOYEES MORE THAN 1600 COMPANIES TRUST US TO HELP THEM STREAMLINE THEIR OPERATIONS, IMPROVE INTER-DEPARTMENTAL EFFICIENCY, AND REDUCE OPERATIONAL OVERHEAD POWERBRIDGE TECHNOLOGIES UNVEILS PLANS TO LEVERAGE CHATGPT TECHNOLOGY FOR EARLY CHILDHOOD EDUCATION ____________ Hello Everyone, We have a new Nasdaq profile that we […]
NYSE: ATNM Profile
OUR NEW PROFILE IS: (NYSE: ATNM) _______________________ H.C. WAINWRIGHT & CO. PLACES $53.00 TARGET ON THIS $14 CLINICAL-STAGE BIOPHARMA STOCK INDICATING MASSIVE POTENTIAL UPSIDE ACTINIUM-225 BASED ALPHA THERAPIES HAVE TREATED APPROXIMATELY 150 PATIENTS TREATED ACROSS SIX PHASE 1 AND PHASE 2 CLINICAL TRIALS ACTINIUM ANNOUNCES POSITIVE FULL DATA RESULTS FROM THE PIVOTAL PHASE 3 SIERRA […]